Kymera Therapeutics
KYMR
KYMR
97 hedge funds and large institutions have $887M invested in Kymera Therapeutics in 2021 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 28 increasing their positions, 25 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
29% less capital invested
Capital invested by funds: $1.25B → $887M (-$360M)
Holders
97
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$43.1M | |
| 2 | +$30.2M | |
| 3 | +$21M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$15.5M |
| 5 |
Morgan Stanley
New York
|
+$13M |
Top Sellers
| 1 | -$39.7M | |
| 2 | -$10.5M | |
| 3 | -$10.5M | |
| 4 |
TOCUITCONY
Trustees of Columbia University in the City of New York
New York
|
-$5.84M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$4.56M |